Sign In
Buy MREO
$0.334
-0.0052 (-1.53%)
At Close: Jun 03, 2026
Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Biopharma Conference
07:30am, Tuesday, 05'th Mar 2024
LONDON, March 05, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today annou
Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments
07:00am, Monday, 08'th Jan 2024
Phase 3 portion of Orbit Study and Phase 3 Cosmic Study of setrusumab for treatment of Osteogenesis Imperfecta (OI) conducted by partner Ultragenyx expected to complete enrollment around the end of 1Q
Mereo BioPharma Reports on Recent Program Developments and Provides Financial Update
04:01pm, Monday, 23'rd Oct 2023
LONDON, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today provid
Mereo BioPharma to Participate in Fireside Chat at the 2023 Cantor Global Healthcare Conference
07:00am, Thursday, 21'st Sep 2023
LONDON, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today annou
Mereo BioPharma Reports Interim Financial Results for the Six Months Ended June 30, 2023 and Provides Corporate Update
07:30am, Thursday, 07'th Sep 2023
LONDON, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today annou
What Makes MEREO BIOPHARMA (MREO) a Strong Momentum Stock: Buy Now?
01:43pm, Friday, 21'st Apr 2023
Does MEREO BIOPHARMA (MREO) have what it takes to be a top stock pick for momentum investors? Let's find out.
4 Hot Penny Stocks To Watch With News This Week
09:01am, Tuesday, 21'st Mar 2023
Penny stocks to watch this week. The post 4 Hot Penny Stocks To Watch With News This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Why Blue Apron Shares Are Trading Lower By 12%; Here Are 20 Stocks Moving Premarket
12:43pm, Monday, 13'th Feb 2023 Benzinga
Gainers
Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares rose 52.5% to $0.7050 in pre-market trading after jumping over 72% on Friday.
EBET, Inc. (NASDAQ: EBET) rose 31.7% to $0.7748 in pre-market
Mereo BioPharma to Participate in Fireside Chat at the SVB Securities Global Biopharma Conference
12:00pm, Wednesday, 08'th Feb 2023 GlobeNewswire Inc.
LONDON, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases and oncolog
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session
05:28pm, Friday, 30'th Dec 2022 Benzinga
Gainers
Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contempl
Why Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday's Mid-Day Session
06:51pm, Wednesday, 21'st Dec 2022 Benzinga
Gainers
Sintx Technologies, Inc. (NASDAQ: SINT) shares climbed 81.4% to $13.55 after the company was awarded Phase I contract for $150,000 from the Missile Defense Agency for electrochemical machini
MEREO BIOPHARMA (MREO) Loses 25.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
02:35pm, Tuesday, 15'th Nov 2022 Zacks Investment Research
The heavy selling pressure might have exhausted for MEREO BIOPHARMA (MREO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street ana
MEREO BIOPHARMA (MREO) Loses 25.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
11:19am, Tuesday, 15'th Nov 2022
The heavy selling pressure might have exhausted for MEREO BIOPHARMA (MREO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street ana
Mereo BioPharma to Host Alvelestat R&D Update Call on October 31, 2022
08:30pm, Monday, 24'th Oct 2022 GlobeNewswire Inc.
LONDON, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO), (“Mereo” or “the Company”), a clinical-stage biopharmaceutical company focused on rare diseases and oncolo
Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting
11:00am, Friday, 21'st Oct 2022 GlobeNewswire Inc.
Reiterates Quality and Composition of Mereo’s Significantly Refreshed Board, which has the Right Skills and Experience to Guide Mereo’s Strategy and Maximize Shareholder Value
